Breaking News

JRS Pharma Receives EXCiPACT GMP Certification for the Production of MCC

The certificate for Changzhou, China facilities helps drug manufacturers reduce efforts and costs.

By: Contract Pharma

Contract Pharma Staff

JRS PHARMA recently announced that the Rettenmaier Natural Fiber Manufacturing facilities in Changzhou, China, were awarded an EXCiPACT Certificate for Good Manufacturing Practices (GMP).
 
This document demonstrates that Rettenmaier Natural Fiber Manufacturing facilities operate according to the EXCiPACT Good Manufacturing Practice (GMP). The certificate helps drug manufacturers reduce efforts and costs as they need to either perform audits of new suppliers or commission third party physical audits to demonstrate GMP compliance. With the institution of new travel restrictions due to COVID-19, EXCiPACT certificates offer customers risk assessment assurance without the need to travel.
 
JRS PHARMA’s line of Microcrystalline Cellulose products produced at the Changzhou facility includes VIVAPUR, a premium tablet binder designed for specific formulation needs. MCC is an odorless, tasteless, white powder with a high degree of brightness, derived from highly purified wood pulp. With a wide range of chemical, technical, and economic benefits, MCC is one of the most widely used binder excipients for solid dosage forms.
 
For more information on VIVAPUR or any of JRS PHARMA’s excipient products, please visit www.jrspharma.com.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters